Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Murdo Gordon
Pharma
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
The company's overall sales grew 23% year over year and 8% excluding contributions from its Horizon Therapeutics buyout to $8.5 billion.
Zoey Becker
Oct 31, 2024 7:50am
In quarterly earnings report, Amgen shows off Lumakras launch
Nov 3, 2021 11:50am
Amgen scores Otezla patent win, nabbing protection until 2028
Sep 21, 2021 10:00am
Early days, but Lumakras expectations are high, Amgen execs say
Aug 5, 2021 9:50am
Amgen contends IRS' bid for $3.6B in back taxes
Aug 4, 2021 8:25am
Otezla's pressures reflected in Amgen's 1st quarter earnings
Apr 28, 2021 9:58am
